Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for iXensor Co., Ltd. (6734:TWSE), powered by AI.
iXensor Co., Ltd. is currently trading at $6.98. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for iXensor Co., Ltd. on Alpha Lenz.
View iXensor Co., Ltd.'s valuation metrics on Alpha Lenz.
“iXensor Co., Ltd.'s ROE is -283.4%. Explore profitability and growth together.”
Ask for details →iXensor Co., Ltd. is a health technology company specializing in digital diagnostics through mobile devices. Founded in 2012, iXensor pioneered the integration of smartphones with lab-grade medical testing, transforming ordinary phones into diagnostic tools via its proprietary PixoTech platform. The company’s core offerings include medical devices for self-monitoring blood glucose, chronic disease management, and women’s health, as well as rapid testing solutions for infectious diseases such as COVID-19. iXensor’s innovative platform enables point-of-care and at-home testing, facilitating real-time data synchronization for healthcare providers and patients. With a strong emphasis on accessibility and data-driven healthcare, iXensor has received multiple international awards and regulatory approvals for its mobile-based testing products. It maintains a distinct role in advancing digital health and remote diagnostics, supporting both consumer wellness and professional healthcare settings in the broader medical equipment and technology sector.
“iXensor Co., Ltd.'s ROE is -283.4%. Explore profitability and growth together.”
Ask for details →iXensor Co., Ltd. (ticker: 6734) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 6.98 with a P/E ratio of -x and P/B of -x.
ROE is -283.37% and operating margin is -170.06%. Annual revenue is $27M.